Related content

The Advantage of Alfacalcidol Over Vitamin D in the Treatment of Osteoporosis

By Shiraishi A.   Higashi S.   Ohkawa H.   Kubodera N.   Hirasawa T.   Ezawa I.   Ikeda K.   Ogata E.  

Calcified Tissue International, Vol. 65, Iss. 4, 1999-10 ,pp. : 311-316

Springer Publishing Company

Access to resources Recommend Favorite

Glucocorticoid-induced Osteoporosis

By Manelli F.F.   Giustina A.A.  

Trends in Endocrinology and Metabolism, Vol. 11, Iss. 3, 2000-04 ,pp. : 79-85

Elsevier

Access to resources Recommend Favorite

Alphacalcidol in Prevention of Glucocorticoid-Induced Osteoporosis

By Reginster J. Y.   de Froidmont C.   Lecart M.-P.   Sarlet N.   Defraigne J.-O.  

Calcified Tissue International, Vol. 65, Iss. 4, 1999-10 ,pp. : 328-331

Springer Publishing Company

Access to resources Recommend Favorite

The Pathogenesis, Epidemiology and Management of Glucocorticoid-Induced Osteoporosis

By Staa T.  

Calcified Tissue International, Vol. 79, Iss. 3, 2006-09 ,pp. : 129-137

Springer Publishing Company

Access to resources Recommend Favorite

Calcium and Vitamin D Therapy in Corticosteroid-Induced Bone Loss: What is the Evidence?

By Adachi J. D.   Ioannidis G.  

Calcified Tissue International, Vol. 65, Iss. 4, 1999-10 ,pp. : 332-336

Springer Publishing Company

Access to resources Recommend Favorite